-
1 Comment
Guangdong Marubi Biotechnology Co., Ltd is currently in a long term downtrend where the price is trading 18.8% below its 200 day moving average.
From a valuation standpoint, the stock is 84.1% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 12.5.
Guangdong Marubi Biotechnology Co., Ltd's total revenue sank by 13.4% to $344M since the same quarter in the previous year.
Its net income has dropped by 32.0% to $70M since the same quarter in the previous year.
Finally, its free cash flow fell by 173.1% to $-66M since the same quarter in the previous year.
Based on the above factors, Guangdong Marubi Biotechnology Co., Ltd gets an overall score of 0/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100003M51 |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Target Price | 31.19 |
|---|---|
| PE Ratio | 53.05 |
| Market Cap | 19B |
| Beta | 0.27 |
| Dividend Yield | None |
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Chunji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603983.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
